Debt-to-equity of AVADEL PHARMACEUTICALS PLC from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Debt-to-equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • AVADEL PHARMACEUTICALS PLC Debt-to-equity for the quarter ending 30 Sep 2025 was 113%, a 4.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 113% +5% +4.6% 30 Sep 2025
Q2 2025 116% +16% +16% 30 Jun 2025
Q1 2025 121% +46% +60% 31 Mar 2025
Q4 2024 118% -16% -12% 31 Dec 2024
Q3 2024 108% -141% -56% 30 Sep 2024
Q2 2024 100% -668% -87% 30 Jun 2024
Q1 2024 76% +944% 31 Mar 2024
Q4 2023 134% -3356% -96% 31 Dec 2023
Q3 2023 249% -307% -55% 30 Sep 2023
Q2 2023 768% +480% +166% 30 Jun 2023
Q1 2023 -869% -1058% -560% 31 Mar 2023
Q4 2022 3491% +3339% +2208% 31 Dec 2022
Q3 2022 556% +433% +353% 30 Sep 2022
Q2 2022 289% +182% +172% 30 Jun 2022
Q1 2022 189% +94% +98% 31 Mar 2022
Q4 2021 151% +34% +29% 31 Dec 2021
Q3 2021 123% -66% -35% 30 Sep 2021
Q2 2021 106% -336% -76% 30 Jun 2021
Q1 2021 95% +1821% 31 Mar 2021
Q4 2020 117% +991% 31 Dec 2020
Q3 2020 189% +1619% 30 Sep 2020
Q2 2020 442% -1398% -76% 30 Jun 2020
Q1 2020 -1726% -2301% -400% 31 Mar 2020
Q4 2019 -874% -1247% -334% 31 Dec 2019
Q3 2019 -1430% -1699% -631% 30 Sep 2019
Q2 2019 1840% +1601% +670% 30 Jun 2019
Q1 2019 575% +345% +150% 31 Mar 2019
Q4 2018 373% +143% +62% 31 Dec 2018
Q3 2018 269% -10% -3.6% 30 Sep 2018
Q2 2018 239% -132% -36% 30 Jun 2018
Q1 2018 230% -197% -46% 31 Mar 2018
Q4 2017 230% -168% -42% 31 Dec 2017
Q3 2017 279% -46% -14% 30 Sep 2017
Q2 2017 371% 30 Jun 2017
Q1 2017 428% 31 Mar 2017
Q4 2016 398% 31 Dec 2016
Q3 2016 325% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.